4//SEC Filing
Gibson Daniel Glenn 4
Accession 0000950170-24-026452
CIK 0001850079other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:07 PM ET
Size
9.1 KB
Accession
0000950170-24-026452
Insider Transaction Report
Form 4
Telesis Bio Inc.TBIO
Gibson Daniel Glenn
Chief Technology Officer
Transactions
- Award
Common Stock
2023-06-22+6,400→ 106,218 total - Tax Payment
Common Stock
2024-03-01$0.53/sh−656$346→ 105,562 total - Award
Stock Option (right to buy)
2023-06-22+51,500→ 51,500 totalExercise: $1.66Exp: 2032-06-22→ Common Stock (51,500 underlying)
Footnotes (3)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 25% of the RSUs shall vest on each of March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027.
- [F2]Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.
- [F3]Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.
Documents
Issuer
Telesis Bio Inc.
CIK 0001850079
Entity typeother
Related Parties
1- filerCIK 0001866133
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:07 PM ET
- Size
- 9.1 KB